Juan Moreno-Rubio (Juan Moreno Rubio)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Ejection Fraction

Top Venues

Cancer research communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sonia Alcalá, Gonzalo Serralta San Martin, Marta Muñoz-Fernández de Legaria, Juan Moreno-Rubio, Silvia Salinas, Juan Carlos López-Gil, José Alberto Rojo López, Javier Martínez Alegre, David Abraham Cortes Bandy, Francisco Zambrana, Ana-María Jiménez-Gordo, Enrique Casado, Miriam López-Gómez, Bruno Sainz
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumor. Cancer research communications (2024)
Lara Paula Fernández, María Merino, Gonzalo Colmenarejo, Juan Moreno-Rubio, Tais González Pessolani, Guillermo Reglero, Enrique Casado, María Sereno, Ana Ramírez de Molina
Metabolic Health Together with a Lipid Genetic Risk Score Predicts Survival of Small Cell Lung Cancer Patients. Cancers 13 (5) (2021)
Lara Paula Fernández, María Merino, Gonzalo Colmenarejo, Juan Moreno-Rubio, Ruth Sánchez-Martínez, Adriana Quijada-Freire, Marta Gómez de Cedrón, Guillermo Reglero, Enrique Casado, María Sereno, Ana Ramírez de Molina
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer. Molecular oncology 14 (12) (2020)